P. L. Meenhorst

1.4k total citations
37 papers, 1.1k citations indexed

About

P. L. Meenhorst is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, P. L. Meenhorst has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 15 papers in Virology and 13 papers in Epidemiology. Recurrent topics in P. L. Meenhorst's work include HIV/AIDS drug development and treatment (18 papers), HIV Research and Treatment (15 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). P. L. Meenhorst is often cited by papers focused on HIV/AIDS drug development and treatment (18 papers), HIV Research and Treatment (15 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). P. L. Meenhorst collaborates with scholars based in Netherlands. P. L. Meenhorst's co-authors include Jos H. Beijnen, Cornelis H.W. Koks, Jan W. Mulder, David M. Burger, Richard M. W. Hoetelmans, Hilde Rosing, Alwin D. R. Huitema, A. Bult, JH Beijnen and Frank P. Kroon and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

P. L. Meenhorst

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. L. Meenhorst Netherlands 19 682 355 261 187 134 37 1.1k
Ralph H. Raasch United States 18 538 0.8× 186 0.5× 368 1.4× 158 0.8× 112 0.8× 42 1.2k
Charlotte M. Harvey United States 9 573 0.8× 469 1.3× 169 0.6× 186 1.0× 53 0.4× 9 1.0k
Natsuo Tachikawa Japan 16 533 0.8× 217 0.6× 284 1.1× 87 0.5× 66 0.5× 74 999
Toshihiro Wajima Japan 23 430 0.6× 248 0.7× 424 1.6× 191 1.0× 108 0.8× 59 1.4k
R. Garraffo France 19 555 0.8× 359 1.0× 313 1.2× 104 0.6× 134 1.0× 92 1.3k
Pieter L. Meenhorst Netherlands 29 1.7k 2.4× 1.3k 3.8× 567 2.2× 167 0.9× 197 1.5× 51 2.3k
J. Durant France 21 1.3k 1.9× 1.1k 3.2× 380 1.5× 217 1.2× 71 0.5× 91 1.9k
Bharat Damle United States 24 1.0k 1.5× 186 0.5× 418 1.6× 196 1.0× 129 1.0× 63 1.8k
Getnet Yimer Ethiopia 21 632 0.9× 163 0.5× 366 1.4× 122 0.7× 149 1.1× 84 1.4k
Lillian Ting Canada 15 537 0.8× 303 0.9× 273 1.0× 146 0.8× 114 0.9× 26 1.1k

Countries citing papers authored by P. L. Meenhorst

Since Specialization
Citations

This map shows the geographic impact of P. L. Meenhorst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. L. Meenhorst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. L. Meenhorst more than expected).

Fields of papers citing papers by P. L. Meenhorst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. L. Meenhorst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. L. Meenhorst. The network helps show where P. L. Meenhorst may publish in the future.

Co-authorship network of co-authors of P. L. Meenhorst

This figure shows the co-authorship network connecting the top 25 collaborators of P. L. Meenhorst. A scholar is included among the top collaborators of P. L. Meenhorst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. L. Meenhorst. P. L. Meenhorst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Joerger, Markus, Alwin D. R. Huitema, P. L. Meenhorst, Jan H.M. Schellens, & Jos H. Beijnen. (2005). Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma. Cancer Chemotherapy and Pharmacology. 55(5). 488–496. 44 indexed citations
2.
Maat, Monique M. R. de, Anthonius de Boer, Cornelis H.W. Koks, et al.. (2004). Evaluation of clinical pharmacist interventions on drug interactions in outpatient pharmaceutical HIV-care. Journal of Clinical Pharmacy and Therapeutics. 29(2). 121–130. 49 indexed citations
3.
Wolters, Leonieke M. M., Hubert G.M. Niesters, Bettina E. Hansen, et al.. (2002). Development of hepatitis B virus resistance for lamivudine in chronic hepatitis B patients co-infected with the human immunodeficiency virus in a Dutch cohort. Journal of Clinical Virology. 24(3). 173–181. 45 indexed citations
4.
Koks, Cornelis H.W., Kristel M. L. Crommentuyn, Richard M. W. Hoetelmans, et al.. (2001). The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV‐1‐infected individuals. British Journal of Clinical Pharmacology. 51(6). 631–635. 19 indexed citations
5.
Veldkamp, Agnes I., Jan W. Mulder, P. L. Meenhorst, et al.. (2001). Steady-State Pharmacokinetics of Twice-Daily Dosing of Saquinavir Plus Ritonavir in HIV-1–Infected Individuals. JAIDS Journal of Acquired Immune Deficiency Syndromes. 27(4). 344–349. 42 indexed citations
6.
Meenhorst, P. L., et al.. (1998). Survival After Massive Ecstasy Overdose. Journal of Toxicology Clinical Toxicology. 36(7). 727–731. 27 indexed citations
7.
Heeswijk, Rolf P. G. van, et al.. (1998). Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection. Journal of Chromatography B Biomedical Sciences and Applications. 719(1-2). 159–168. 100 indexed citations
8.
Hoetelmans, Richard M. W., Cornelis H.W. Koks, Jos H. Beijnen, et al.. (1997). Clinical pharmacology of HIV protease inhibitors: focus on saquinavir, indinavir, and ritonavir.. Pharmacy World & Science. 19(4). 159–175. 76 indexed citations
10.
Burger, David M., et al.. (1994). Pharmacokinetics of Zidovudine and Metabolites in a Patient with HIV-Associated Nephropathy and Severe Renal Impairment. Clinical Drug Investigation. 7(5). 282–287. 5 indexed citations
11.
Burger, David M., L.J.C. van Warmerdam, Hilde Rosing, et al.. (1993). Development and Validation of Limited-Sampling Models for the Antiretroviral Agent Zidovudine. Clinical Drug Investigation. 6(4). 189–197. 4 indexed citations
12.
Bekers, Otto, Jos H. Beijnen, David M. Burger, et al.. (1993). 2′,3′-Dideoxyinosine (ddI): Its chemical stability and cyclodextrin complexation in aqueous media. Journal of Pharmaceutical and Biomedical Analysis. 11(6). 489–493. 12 indexed citations
13.
Burger, David M., et al.. (1993). Ocular complications of the acquired immunodeficiency syndrome. Pharmacy World & Science. 15(2). 56–67. 4 indexed citations
14.
Burger, David M., Hilde Rosing, Franciska J. Koopman, et al.. (1993). Determination of 3'-amino-3'-deoxythymidine, a cytotoxic metabolite of 3'-azido-3'-deoxythymidine, in human plasma by ion-pair high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 622(2). 235–242. 12 indexed citations
15.
Burger, David M., et al.. (1992). Determination of stavudine, a new antiretroviral agent, in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection. Journal of Chromatography B Biomedical Sciences and Applications. 584(2). 239–247. 30 indexed citations
16.
Meenhorst, P. L., et al.. (1992). Didanosine, a new antiretroviral drug. Pharmacy World & Science. 14(5). 297–304. 3 indexed citations
17.
Pos, Odette, et al.. (1992). Impaired phagocytosis ofStaphylococcus aureusby granulocytes and monocytes of AIDS patients. Clinical & Experimental Immunology. 88(1). 23–28. 42 indexed citations
18.
Beijnen, Jos H., et al.. (1991). HPLC determination of doxorubicin, doxorubicinol and four aglycone metabolites in plasma of AIDS patients. Journal of Pharmaceutical and Biomedical Analysis. 9(10-12). 995–1002. 40 indexed citations
19.
Beijnen, Jos H., et al.. (1991). Gas chromatographic analysis, with electron capture detection, of the antifungal drug fluconazole in microvolumes of human plasma. Journal of Pharmaceutical and Biomedical Analysis. 9(10-12). 1173–1175. 9 indexed citations
20.
Meenhorst, P. L., J.W.M. van der Meer, & P. van Brummelen. (1978). [A patient with legionnaires' disease in the Netherlands].. PubMed. 122(15). 1128–10. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026